{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:44:06Z","timestamp":1793504646052,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70114225"],"award-info":[{"award-number":["70114225"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70117363"],"award-info":[{"award-number":["70117363"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70117362"],"award-info":[{"award-number":["70117362"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["455784452"],"award-info":[{"award-number":["455784452"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["414786233"],"award-info":[{"award-number":["414786233"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["501530074"],"award-info":[{"award-number":["501530074"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["269925409"],"award-info":[{"award-number":["269925409"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Culture and Science of the State of North Rhine-Westphalia\u00b4, initiative \"Netzwerke 2021\": CANTAR project"},{"name":"Koeln Fortune Program, Faculty of Medicine, University of Cologne"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tumour necrosis factor (TNF) is a pleiotropic cytokine originally identified for its ability to kill cancer cells. However, a paradoxical tumour-promoting role for TNF emerged when early attempts to exploit its anti-tumour activity in cancer therapy produced conflicting outcomes, raising the question of whether TNF should be viewed as a therapeutic agent or a treatment target in cancer. Here, we demonstrate that expression of cFLIP, a catalytically inactive paralogue of caspase-8 (CASP8), determines the susceptibility of melanoma cells to TNF and thereby controls melanoma growth in a syngeneic, immune-competent mouse model of B16F10 cutaneous melanoma. B16F10 melanoma cells lacking cFLIP (\n                    <jats:italic>cFlip<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>KO\/KO<\/jats:italic>\n                    <\/jats:sup>\n                    cells) failed to grow in wild-type mice, whereas in TNF-deficient mice,\n                    <jats:italic>cFlip<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>KO\/KO<\/jats:italic>\n                    <\/jats:sup>\n                    melanoma cells formed palpable tumours and exhibited robust subcutaneous growth. These findings indicate that TNF alone is sufficient to control melanoma growth in the absence of cFLIP. Importantly, the anti-tumour activity of TNF has predominantly been investigated through targeting cellular inhibitors of apoptosis proteins (cIAPs), which promotes RIPK1 activation and TNF-induced cytotoxicity. We show that genomic ablation of cIAPs or RIPK1, in contrast to cFLIP, neither triggered TNF-induced toxicity nor affected melanoma growth in vivo. Collectively, our data underscore the central role of cFLIP in regulating melanoma responses to TNF and suggest that endogenous immune surveillance as well as immunotherapies involving TNF could strongly benefit from cFLIP targeting strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09154-6","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:06:28Z","timestamp":1785589588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The anti-tumour activity of TNF in melanoma is determined by cFLIP"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7419-8900","authenticated-orcid":false,"given":"Johanna","family":"Stachelscheid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8239-5576","authenticated-orcid":false,"given":"C\u00e4cilia","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Gerstenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Werthenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Schorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-3818","authenticated-orcid":false,"given":"Joy","family":"Steinkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Zigrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-0966","authenticated-orcid":false,"given":"Manolis","family":"Pasparakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars M.","family":"Schiffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2796-1429","authenticated-orcid":false,"given":"Hamid","family":"Kashkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"9154_CR1","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1038\/sj.onc.1206454","volume":"22","author":"MS Soengas","year":"2003","unstructured":"Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene. 2003;22:3138\u201351.","journal-title":"Oncogene"},{"key":"9154_CR2","doi-asserted-by":"crossref","unstructured":"Wang M, Zhao JH, Tang MX, Li M, Zhao H, Li ZY, et al. Cell death modalities in therapy of melanoma. Int J Mol Sci. 2025;26.","DOI":"10.3390\/ijms26083475"},{"key":"9154_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395\u2013417.","journal-title":"Nat Rev Clin Oncol"},{"key":"9154_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/imr.12541","volume":"277","author":"B Tummers","year":"2017","unstructured":"Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev. 2017;277:76\u201389.","journal-title":"Immunol Rev"},{"key":"9154_CR5","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1016\/j.molcel.2025.09.028","volume":"85","author":"H Kashkar","year":"2025","unstructured":"Kashkar H, Pasparakis M. Cell-death networks. Mol Cell. 2025;85:3890\u2013e1.","journal-title":"Mol Cell"},{"key":"9154_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187:235\u201356.","journal-title":"Cell"},{"key":"9154_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature14191","volume":"517","author":"M Pasparakis","year":"2015","unstructured":"Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517:311\u201320.","journal-title":"Nature"},{"key":"9154_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/BJ20101738","volume":"433","author":"C Pop","year":"2011","unstructured":"Pop C, Oberst A, Drag M, Van Raam BJ, Riedl SJ, Green DR, et al. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem J. 2011;433:447\u201357.","journal-title":"Biochem J"},{"key":"9154_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20806-9","volume":"12","author":"JL Fox","year":"2021","unstructured":"Fox JL, Hughes MA, Meng X, Sarnowska NA, Powley IR, Jukes-Jones R, et al. Cryo-EM structural analysis of FADD:Caspase-8 complexes defines the catalytic dimer architecture for co-ordinated control of cell fate. Nat Commun. 2021;12:819.","journal-title":"Nat Commun"},{"key":"9154_CR10","doi-asserted-by":"crossref","unstructured":"Newton, Wickliffe K, Maltzman KE, Dugger A, Reyes DL, Jr J, et al. cFLIP suppresses caspase-1- and MLKL-independent perinatal lethality driven by auto-processing impaired caspase-8 D387A. Cell Death Differ. 2025.","DOI":"10.1038\/s41418-025-01650-0"},{"key":"9154_CR11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2415992122","volume":"122","author":"JJP Shaw","year":"2025","unstructured":"Shaw JJP, Guy C, Tummers B, Green DR. FLIP(L) permits apoptotic and inflammatory signaling and inhibits necroptosis in mice without Caspase-8 oligomerization. Proc Natl Acad Sci USA. 2025;122:e2415992122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9154_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114:181\u201390.","journal-title":"Cell"},{"key":"9154_CR13","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","volume":"72","author":"EA Carswell","year":"1975","unstructured":"Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975;72:3666\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9154_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/258731a0","volume":"258","author":"L Helson","year":"1975","unstructured":"Helson L, Green S, Carswell E, Old LJ. Effect of tumour necrosis factor on cultured human melanoma cells. Nature. 1975;258:731\u20132.","journal-title":"Nature"},{"key":"9154_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361\u201371.","journal-title":"Nat Rev Cancer"},{"key":"9154_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.celrep.2013.02.014","volume":"3","author":"K Brinkmann","year":"2013","unstructured":"Brinkmann K, Zigrino P, Witt A, Schell M, Ackermann L, Broxtermann P, et al. Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXA. Cell Rep. 2013;3:881\u201391.","journal-title":"Cell Rep"},{"key":"9154_CR17","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202153608","volume":"23","author":"M Daoud","year":"2022","unstructured":"Daoud M, Broxtermann PN, Schorn F, Werthenbach JP, Seeger JM, Schiffmann LM, et al. XIAP promotes melanoma growth by inducing tumour neutrophil infiltration. EMBO Rep. 2022;23:e53608.","journal-title":"EMBO Rep"},{"key":"9154_CR18","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1158\/0008-5472.CAN-09-3175","volume":"70","author":"JM Seeger","year":"2010","unstructured":"Seeger JM, Schmidt P, Brinkmann K, Hombach AA, Coutelle O, Zigrino P, et al. The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack. Cancer Res. 2010;70:1825\u201334.","journal-title":"Cancer Res"},{"key":"9154_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/exd.70144","volume":"34","author":"J Steinkamp","year":"2025","unstructured":"Steinkamp J, Mersch N, Kashkar H, Zigrino P. Targeting XIAP and EGFR as an Approach for Treating Melanoma. Exp Dermatol. 2025;34:e70144.","journal-title":"Exp Dermatol"},{"key":"9154_CR20","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1182\/blood-2006-10-053959","volume":"109","author":"H Kashkar","year":"2007","unstructured":"Kashkar H, Deggerich A, Seeger JM, Yazdanpanah B, Wiegmann K, Haubert D, et al. NF-kappaB-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs. Blood. 2007;109:3982\u20138.","journal-title":"Blood"},{"key":"9154_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/sj.cdd.4401024","volume":"9","author":"H Kashkar","year":"2002","unstructured":"Kashkar H, Kronke M, Jurgensmeier JM. Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis. Cell Death Differ. 2002;9:750\u20137.","journal-title":"Cell Death Differ"},{"key":"9154_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","volume":"575","author":"M Fritsch","year":"2019","unstructured":"Fritsch M, Gunther SD, Schwarzer R, Albert MC, Schorn F, Werthenbach JP, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019;575:683\u20137.","journal-title":"Nature"},{"key":"9154_CR23","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8:2281\u2013308.","journal-title":"Nat Protoc"},{"key":"9154_CR24","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2023113614","volume":"42","author":"F Schorn","year":"2023","unstructured":"Schorn F, Werthenbach JP, Hoffmann M, Daoud M, Stachelscheid J, Schiffmann LM, et al. cIAPs control RIPK1 kinase activity-dependent and -independent cell death and tissue inflammation. EMBO J. 2023;42:e113614.","journal-title":"EMBO J"},{"key":"9154_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41564-019-0620-5","volume":"5","author":"SD Gunther","year":"2020","unstructured":"Gunther SD, Fritsch M, Seeger JM, Schiffmann LM, Snipas SJ, Coutelle M, et al. Cytosolic Gram-negative bacteria prevent apoptosis by inhibition of effector caspases through lipopolysaccharide. Nat Microbiol. 2020;5:354\u201367.","journal-title":"Nat Microbiol"},{"key":"9154_CR26","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1084\/jem.184.4.1397","volume":"184","author":"M Pasparakis","year":"1996","unstructured":"Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med. 1996;184:1397\u2013411.","journal-title":"J Exp Med"},{"key":"9154_CR27","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/emmm.201303016","volume":"6","author":"O Coutelle","year":"2014","unstructured":"Coutelle O, Hornig-Do HT, Witt A, Andree M, Schiffmann LM, Piekarek M, et al. Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing. EMBO Mol Med. 2014;6:624\u201339.","journal-title":"EMBO Mol Med"},{"key":"9154_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17472-2","volume":"11","author":"LM Schiffmann","year":"2020","unstructured":"Schiffmann LM, Werthenbach JP, Heintges-Kleinhofer F, Seeger JM, Fritsch M, Gunther SD, et al. Mitochondrial respiration controls neoangiogenesis during wound healing and tumour growth. Nat Commun. 2020;11:3653.","journal-title":"Nat Commun"},{"key":"9154_CR29","doi-asserted-by":"publisher","first-page":"719","DOI":"10.15252\/embr.201439616","volume":"16","author":"A Witt","year":"2015","unstructured":"Witt A, Seeger JM, Coutelle O, Zigrino P, Broxtermann P, Andree M, et al. IAP antagonization promotes inflammatory destruction of vascular endothelium. EMBO Rep. 2015;16:719\u201327.","journal-title":"EMBO Rep"},{"key":"9154_CR30","doi-asserted-by":"publisher","first-page":"e102022","DOI":"10.1371\/journal.pone.0102022","volume":"9","author":"MK Kylaniemi","year":"2014","unstructured":"Kylaniemi MK, Kaukonen R, Myllyviita J, Rasool O, Lahesmaa R. The regulation and role of c-FLIP in human Th cell differentiation. PLoS One. 2014;9:e102022.","journal-title":"PLoS One"},{"key":"9154_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","volume":"131","author":"E Varfolomeev","year":"2007","unstructured":"Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell. 2007;131:669\u201381.","journal-title":"Cell"},{"key":"9154_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cell.2007.10.037","volume":"131","author":"JE Vince","year":"2007","unstructured":"Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU, et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell. 2007;131:682\u201393.","journal-title":"Cell"},{"key":"9154_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15466-8","volume":"11","author":"L Laurien","year":"2020","unstructured":"Laurien L, Nagata M, Schunke H, Delanghe T, Wiederstein JL, Kumari S, et al. Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation. Nat Commun. 2020;11:1747.","journal-title":"Nat Commun"},{"key":"9154_CR34","doi-asserted-by":"publisher","first-page":"E2001","DOI":"10.1073\/pnas.1722013115","volume":"115","author":"H Meng","year":"2018","unstructured":"Meng H, Liu Z, Li X, Wang H, Jin T, Wu G, et al. Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis. Proc Natl Acad Sci USA. 2018;115:E2001\u2013E9.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9154_CR35","doi-asserted-by":"crossref","unstructured":"Newton K. Multitasking kinase RIPK1 regulates cell death and inflammation. Cold Spring Harb Perspect Biol. 2020;12.","DOI":"10.1101\/cshperspect.a036368"},{"key":"9154_CR36","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1126\/science.1249361","volume":"343","author":"K Newton","year":"2014","unstructured":"Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, Vucic D, et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science. 2014;343:1357\u201360.","journal-title":"Science"},{"key":"9154_CR37","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1042\/BCJ20210725","volume":"479","author":"E Varfolomeev","year":"2022","unstructured":"Varfolomeev E, Vucic D. RIP1 post-translational modifications. Biochem J. 2022;479:929\u201351.","journal-title":"Biochem J"},{"key":"9154_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.240","volume":"6","author":"P Geserick","year":"2015","unstructured":"Geserick P, Wang J, Schilling R, Horn S, Harris PA, Bertin J, et al. Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death Dis. 2015;6:e1884.","journal-title":"Cell Death Dis"},{"key":"9154_CR39","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2014.04.018","volume":"157","author":"CP Dillon","year":"2014","unstructured":"Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, Quarato G, Gurung P, et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell. 2014;157:1189\u2013202.","journal-title":"Cell"},{"key":"9154_CR40","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1073\/pnas.1401857111","volume":"111","author":"WJ Kaiser","year":"2014","unstructured":"Kaiser WJ, Daley-Bauer LP, Thapa RJ, Mandal P, Berger SB, Huang C, et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc Natl Acad Sci USA. 2014;111:7753\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9154_CR41","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","volume":"157","author":"JA Rickard","year":"2014","unstructured":"Rickard JA, O\u2019Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell. 2014;157:1175\u201388.","journal-title":"Cell"},{"key":"9154_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55006-2","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu X, Lu D, Qi X, Paudel RR, Lin H, Holloman BL, et al. Development of a RIPK1 degrader to enhance antitumor immunity. Nat Commun. 2024;15:10683.","journal-title":"Nat Commun"},{"key":"9154_CR43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2230.2011.04238.x","volume":"37","author":"F Tian","year":"2012","unstructured":"Tian F, Lu JJ, Wang L, Li L, Yang J, Li Y, et al. Expression of c-FLIP in malignant melanoma, and its relationship with the clinicopathological features of the disease. Clin Exp Dermatol. 2012;37:259\u201365.","journal-title":"Clin Exp Dermatol"},{"key":"9154_CR44","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1038\/sj.onc.1210985","volume":"27","author":"P Geserick","year":"2008","unstructured":"Geserick P, Drewniok C, Hupe M, Haas TL, Diessenbacher P, Sprick MR, et al. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis. Oncogene. 2008;27:3211\u201320.","journal-title":"Oncogene"},{"key":"9154_CR45","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1158\/1078-0432.CCR-14-3156","volume":"22","author":"AK Srivastava","year":"2016","unstructured":"Srivastava AK, Jaganathan S, Stephen L, Hollingshead MG, Layhee A, Damour E, et al. Effect of a Smac mimetic (TL32711, Birinapant) on the apoptotic program and apoptosis biomarkers examined with validated multiplex immunoassays fit for clinical use. Clin Cancer Res. 2016;22:1000\u201310.","journal-title":"Clin Cancer Res"},{"key":"9154_CR46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.trecan.2021.12.002","volume":"8","author":"NV Ivanisenko","year":"2022","unstructured":"Ivanisenko NV, Seyrek K, Hillert-Richter LK, Konig C, Espe J, Bose K, et al. Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks. Trends Cancer. 2022;8:190\u2013209.","journal-title":"Trends Cancer"},{"key":"9154_CR47","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1158\/0008-5472.CAN-14-2524","volume":"75","author":"F Bertrand","year":"2015","unstructured":"Bertrand F, Rochotte J, Colacios C, Montfort A, Tilkin-Mariame AF, Touriol C, et al. Blocking tumor necrosis factor alpha enhances CD8 T-cell-dependent immunity in experimental melanoma. Cancer Res. 2015;75:2619\u201328.","journal-title":"Cancer Res"},{"key":"9154_CR48","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/annonc\/mdt027","volume":"24","author":"J Delyon","year":"2013","unstructured":"Delyon J, Mateus C, Lefeuvre D, Lanoy E, Zitvogel L, Chaput N, et al. Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival. Ann Oncol. 2013;24:1697\u2013703.","journal-title":"Ann Oncol"},{"key":"9154_CR49","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711\u201323.","journal-title":"N Engl J Med"},{"key":"9154_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41584-021-00584-4","volume":"17","author":"AY Chen","year":"2021","unstructured":"Chen AY, Wolchok JD, Bass AR. TNF in the era of immune checkpoint inhibitors: friend or foe? Nat Rev Rheumatol. 2021;17:213\u201323.","journal-title":"Nat Rev Rheumatol"},{"key":"9154_CR51","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ijc.35416","volume":"157","author":"M Virazels","year":"2025","unstructured":"Virazels M, Lusque A, Brayer S, Genais M, Dufau C, Milhes J, et al. TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: results from the MELANFalpha clinical study. Int J Cancer. 2025;157:534\u201348.","journal-title":"Int J Cancer"},{"key":"9154_CR52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","volume":"23","author":"G van Loo","year":"2023","unstructured":"van Loo G, Bertrand MJM. Death by TNF: a road to inflammation. Nat Rev Immunol. 2023;23:289\u2013303.","journal-title":"Nat Rev Immunol"},{"key":"9154_CR53","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.3389\/fimmu.2019.01818","volume":"10","author":"A Montfort","year":"2019","unstructured":"Montfort A, Colacios C, Levade T, Andrieu-Abadie N, Meyer N, Segui B. The TNF Paradox in Cancer Progression and Immunotherapy. Front Immunol. 2019;10:1818.","journal-title":"Front Immunol"},{"key":"9154_CR54","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.it.2021.10.003","volume":"42","author":"AJ Freeman","year":"2021","unstructured":"Freeman AJ, Kearney CJ, Silke J, Oliaro J. Unleashing TNF cytotoxicity to enhance cancer immunotherapy. Trends Immunol. 2021;42:1128\u201342.","journal-title":"Trends Immunol"},{"key":"9154_CR55","first-page":"176","volume":"34","author":"AR Safa","year":"2012","unstructured":"Safa AR. c-FLIP, a master anti-apoptotic regulator. Exp Oncol. 2012;34:176\u201384.","journal-title":"Exp Oncol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09154-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09154-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09154-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:25:28Z","timestamp":1785590728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09154-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9154"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09154-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All mouse experiments were approved by local authorities (LAVE, North Rhine-Westphalia, Germany) and conducted in accordance with the German animal protection law under the license number 84-02.04.2017.A166. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"671"}}